Targeted Therapies in B-Cell Malignancies: ASH 2023 and Beyond

Expert Nicole Lamanna, MD, reviews the clinical evolution of targeted therapies in in B-cell malignancies, highlighting the latest data in CLL to be presented at the upcoming ASH 2023 annual congress.

EP. 1: Looking Ahead to Upcoming Presentations at ASH 2023

December 5th 2023

Expert insights into the evolving treatment landscape for chronic lymphocytic leukemia (CLL), emphasizing upcoming clinical data to be presented at ASH 2023.

EP. 2: Targeted Therapy and Role of Biomarkers in B-Cell Malignancies

December 21st 2023

Nicole Lamanna, MD, gives an overview of targeted therapies and the role of prognostic markers in the treatment of B-cell malignancies.

EP. 3: CLL: Updated Data in the Frontline Setting Presented at ASH 2023

December 21st 2023

A hematologist/oncologist previews updated data presented at ASH 2023 for patients with B-cell malignancies.

EP. 4: Zanubrutinib Plus Sonrotoclax in Patients With Treatment-Naïve CLL/SLL

December 21st 2023

Nicole Lamanna, MD, discusses the results from the ongoing BGB-11417-101 study investigating combination zanubrutinib plus sonrotoclax in patients with treatment-naïve CLL/SLL.

EP. 5: Recent Data in Relapsed/Refractory CLL/SLL

December 27th 2023

An expert on hematologic malignancies discusses recent data from ASH 2023 in relapsed/refractory CLL/SLL, highlighting the ALPINE study investigating zanubrutinib versus ibrutinib.

EP. 6: Adverse Events for BTK Inhibitors and BCL2 Inhibitors in CLL

December 27th 2023

Expert perspectives on the toxicities seen with targeted therapies in chronic lymphocytic leukemia and how they’re mitigated and managed.

EP. 7: Treatment Sequencing for Patients With B-Cell Malignancies

January 3rd 2024

Comprehensive insights on clinical and patient factors that inform treatment selection and sequencing for patients with B-cell malignancies.

EP. 8: Ongoing Research on Targeted Therapy in Relapsed/Refractory CLL

January 3rd 2024

A hematologist/oncologist discusses ongoing research on targeted therapy for patients with relapsed/refractory chronic lymphocytic leukemia.

EP. 9: Future of Treatment of B-Cell Malignancies

January 10th 2024

Nicole Lamanna, MD, looks ahead at the future of treatment of B-cell malignancies, highlighting exciting therapeutic developments.